Receptors, Antigen, T-Cell

DBCAT005635Pharmacologic class

Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). A DrugBank category of 2 drugs. 2 of them are approved.

Drugs: Brexucabtagene autoleucel
Idecabtagene vicleucel

What you can answer from here — as of January 13, 2022

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

8Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Receptors, Antigen, T-Cell share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account